Fortis Healthcare shares rose 2.94% to ₹895.85 following the announcement of definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital for healthcare services at a 400+ bed super speciality hospital in Ashok Vihar, New Delhi. According to Business Standard, this positive market reaction reflects investor confidence in the strategic partnership's long-term value. The stock movement demonstrates market approval of the company's asset-light expansion model that allows Fortis to expand its Delhi-NCR footprint to more than 3,400 beds without adding fixed assets to its balance sheet.
Fortis Healthcare has filed a Special Leave Petition in the Supreme Court against the Delhi High Court order mandating a six-month forensic audit of transactions linked to Fortis Healthcare, IHH Healthcare, and RHT Health Trust in the Daiichi Sankyo case. The Delhi High Court issued this order on August 31, 2026, creating significant legal uncertainty for the company. The underlying Daiichi Sankyo dispute involves an outstanding claims balance estimated at ₹5,300 crore against the former promoters, with Daiichi Sankyo claiming that outstanding dues have risen to approximately ₹5,300 crore from the original Singapore arbitration award of ₹2,562 crore from April 2016. If the company successfully secures a legal stay at the Supreme Court, it will further solidify its separation from legacy promoter liabilities.
Fortis Healthcare Ltd has signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital (SLJ Society) to provide healthcare services at a 400+ bed super speciality hospital in Ashok Vihar, New Delhi. According to the latest press release dated September 16, 2026, the agreements were executed by Fortis Hospotel Ltd (FHTL), a wholly-owned subsidiary of Fortis Healthcare. The hospital is expected to commence operations in 3-4 years, subject to necessary approvals, with Fortis securing exclusive rights to provide specified inpatient healthcare services under a 29-year agreement. This asset-light expansion model allows Fortis to expand its Delhi-NCR footprint to more than 3,400 beds without adding fixed assets to its balance sheet, keeping its business expansion completely insulated from legal proceedings.
Under the Healthcare Services Agreement (HSA), FHTL will have long-term exclusive rights to provide specified inpatient healthcare services and specialised equipment at the hospital. As reported by CNBC TV18 and Business Standard, these include a Cath Lab, LINAC, PET-CT and surgical robot, among others. The HSA has a committed term of 29 years, with an option to extend it for a further period on mutually agreed terms. FHTL will receive an agreed service fee from SLJ Society calculated as a percentage of the revenue generated by the hospital, and will also bring in the necessary clinical manpower for providing the healthcare services. The latest agreement also includes a loan facility of ₹567 crore to be disbursed in multiple tranches over the next 3-4 years based on construction progress, with FHTL entitled to receive interest as per the Loan Agreement terms.
Fortis Healthcare reported strong financial performance for the first quarter ended June 30, 2026, with consolidated revenues of ₹2,545 crore, up 17.46% YoY, and consolidated net profit of ₹266.39 crore, up 2.35% YoY. According to Business Standard, this robust operational momentum demonstrates the company's ability to generate cash flows and execute business expansion plans despite ongoing legal challenges. The company's expansion footprint in the highly competitive Delhi-NCR healthcare corridor has advanced via this partnership for a new 400+ bed super-specialty hospital, with the ₹567 crore loan facility structured through phased tranches over the next 3-4 years based on construction progress. Fortis currently operates 36 healthcare facilities across 12 states, with more than 6,150 operational beds and around 400 diagnostics laboratories.
The hospital will be owned, operated and managed by SLJ Society, while Fortis will provide healthcare services to the society. According to the latest press release, SLJ Society will own and develop the land, building, associated civil infrastructure and certain medical infrastructure. The facility will be developed as a state-of-the-art facility on around 3.1 acres of land in Ashok Vihar, North-West Delhi, with a planned capacity of 400+ beds that will be operationalized in phases. The hospital will offer tertiary and quaternary healthcare services across specialties including oncology, neurosciences, cardiac sciences, gastroenterology, orthopaedics and renal sciences. It will also provide multi-specialty robotic surgeries and transplant services, fulfilling applicable regulatory and social obligations by providing free inpatient and outpatient treatment to eligible patients under the Economically Weaker Sections (EWS) category. Dr Ashutosh Raghuvanshi, MD & CEO of the Company, emphasized that this collaboration aims to enhance access to quality healthcare in North-West Delhi, an underserved micro-market characterized by a dense residential population.
